A 2‐year review of publicly funded cell‐free DNA screening in Ontario: utilization and adherence to funding criteria
Prenatal Diagnosis2019Vol. 40(2), pp. 164–172
Citations Over TimeTop 12% of 2019 papers
Kara Bellai‐Dussault, Lynn Meng, Tianhua Huang, Jessica Reszel, Mark Walker, Andrea Lanes, Nanette Okun, Christine M. Armour, Shelley Dougan
Abstract
Reviewing and auditing the application of criteria for funded cfDNA screening using prescribed registry data allows an opportunity to identify areas where targeted education may improve adherence to standardized screening protocols, and provides a basis for reassessment of the funding model.
Related Papers
- → Maternal Malignancy Evaluation After Discordant Cell-Free DNA Results(2018)43 cited
- → Cell-free DNA testing: An aid to prenatal sonographic diagnosis(2014)7 cited
- → Cell-Free DNA Testing(2016)
- Research Progress of Cell-free Fetal DNA in Prenatal Diagnosis of Aneuploidy(2010)
- → Appling cell-free fetal DNA and RNA of maternal plasma in non-invasive prenatal diagnosis(2013)